Author:
Braun J,van den Berg R,Baraliakos X,Boehm H,Burgos-Vargas R,Collantes-Estevez E,Dagfinrud H,Dijkmans B,Dougados M,Emery P,Geher P,Hammoudeh M,Inman RD,Jongkees M,Khan MA,Kiltz U,Kvien TK,Leirisalo-Repo M,Maksymowych WP,Olivieri I,Pavelka K,Sieper J,Stanislawska-Biernat E,Wendling D,Özgocmen S,van Drogen C,van Royen BJ,van der Heijde D
Abstract
This first update of the ASAS/EULAR recommendations on the management of ankylosing spondylitis (AS) is based on the original paper, a systematic review of existing recommendations and the literature since 2005 and the discussion and agreement among 21 international experts, 2 patients and 2 physiotherapists in a meeting in February 2010. Each original bullet point was discussed in detail and reworded if necessary. Decisions on new recommendations were made — if necessary after voting. The strength of the recommendations (SOR) was scored on an 11-point numerical rating scale after the meeting by email. These recommendations apply to patients of all ages that fulfill the modified NY criteria for AS, independent of extra-articular manifestations, and they take into account all drug and non-drug interventions related to AS. Four overarching principles were introduced, implying that one bullet has been moved to this section. There are now 11 bullet points including 2 new ones, one related to extra-articular manifestations and one to changes in the disease course. With a mean score of 9.1 (range 8-10) the SOR was generally very good.
Subject
General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology